Consistent with the in vitro data, FXR expression was downregulated in human bladder cancer tissues, compared to the adjacent normal tissues, and a higher expression of FXR was significantly associated with a better clinical outcome [138]. The gene discussed is NR1H4; the disease is urinary bladder cancer.